Erin Gatza and Craig Y. Okada. Tumor Cell Lysate-Pulsed Dendritic Cells Are More Effective Than TCR Id Protein Vaccines for Active Immunotherapy of T Cell Lymphoma. The Journal of Immunology 2002;169:5227–5235 .

The authors of this paper neglected to identify the source of a reagent used in the study. The source of the reagent is stated below.

“The C6VL TCR Id vaccine used in this study was prepared by conjugating recombinant TCR Id protein to KLH and mixing the conjugate with QS-21. QS-21 was provided by Antigenics, Inc. (Framingham, MA) under a material transfer agreement.”